Table of Contents

1 Product Introduction and Overview

• 1.1 Product Definition
• 1.2 Product Specification
• 1.3 Global Market Overview
  • 1.3.1 Global Controlled Substances Market Status and Forecast (2016-2027)
  • 1.3.2 Global Controlled Substances Sales Value CAGR by Region
• 1.4 Market Drivers, Inhibitors
  • 1.4.1 Market Drivers
  • 1.4.2 Market Inhibitors
  • 1.4.3 COVID-19 Impact Analysis

2 Global Controlled Substances Supply by Company

• 2.1 Global Controlled Substances Sales Value by Company
• 2.2 Controlled Substances Sales Area of Main Manufacturers
• 2.3 Trend of Concentration Rate

3 Global and Regional Controlled Substances Market Status by Category

• 3.1 Controlled Substances Category Introduction
  • 3.1.1 Opioids
  • 3.1.2 Stimulants
  • 3.1.3 Depressants
  • 3.1.4 Marijuana
  • 3.1.5 Others
• 3.2 Global Controlled Substances Market by Category
• 3.3 North America: by Category
• 3.4 Europe: by Category
• 3.5 Asia Pacific: by Category
• 3.6 Central & South America: by Category
• 3.7 Middle East & Africa: by Category

4 Global and Regional Controlled Substances Market Status by End User/Segment

• 4.1 Controlled Substances Segment by End User/Segment
  • 4.1.1 Hospital Pharmacies
  • 4.1.2 Retail Pharmacies
  • 4.1.3 Online Pharmacies
• 4.2 Global Controlled Substances Market by End User/Segment
• 4.3 North America: by End User/Segment
• 4.4 Europe: by End User/Segment
• 4.5 Asia Pacific: by End User/Segment
• 4.6 Central & South America: by End User/Segment
• 4.7 Middle East & Africa: by End User/Segment

5 Global Controlled Substances Market Status by Region

• 5.1 Global Controlled Substances Market by Region
• 5.2 North America Controlled Substances Market Status
• 5.3 Europe Controlled Substances Market Status
• 5.4 Asia Pacific Controlled Substances Market Status
• 5.5 Central & South America Controlled Substances Market Status
• 5.6 Middle East & Africa Controlled Substances Market Status

6 North America Controlled Substances Market Status

• 6.1 North America Controlled Substances Market by Country
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe Controlled Substances Market Status

• 7.1 Europe Controlled Substances Market by Country
• 7.2 Germany
• 7.3 France
• 7.4 UK
• 7.5 Italy
• 7.6 Russia
• 7.7 Spain

8 Asia Pacific Controlled Substances Market Status

• 8.1 Asia Pacific Controlled Substances Market by Country
• 8.2 China
• 8.3 Japan
• 8.4 Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australasia

9 Central & South America Controlled Substances Market Status

• 9.1 Central & South America Controlled Substances Market by Country
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Colombia

10 Middle East & Africa Controlled Substances Market Status

• 10.1 Middle East & Africa Controlled Substances Market by Country
• 10.2 Iran
• 10.3 Israel
• 10.4 Turkey
• 10.5 South Africa
• 10.8 Saudi Arabia

11 Major Downstream Customers Analysis

• 11.1 Customer One Analysis
• 11.2 Customer Two Analysis
• 11.3 Customer Three Analysis
• 11.4 Customer Four Analysis

12 Global Controlled Substances Market Forecast by Category and by End User/Segment

• 12.1 Global Controlled Substances Sales Value Forecast (2022-2027)
• 12.2 Global Controlled Substances Forecast by Category
• 12.3 Global Controlled Substances Forecast by End User/Segment

13 Global Controlled Substances Market Forecast by Region/Country

• 13.1 Global Controlled Substances Market Forecast by Region (2022-2027)
• 13.2 North America Market Forecast
• 13.3 Europe Market Forecast
• 13.4 Asia Pacific Market Forecast
• 13.5 Central & South America Market Forecast
• 13.6 Middle East & Africa Market Forecast

14 Key Participants Company Information

• 14.1 Tilray
  • 14.1.1 Company Information
  • 14.1.2 Controlled Substances Product Introduction
  • 14.1.3 Tilray Controlled Substances Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.1.4 SWOT Analysis
• 14.2 Teva Pharmaceuticals
  • 14.2.1 Company Information
  • 14.2.2 Controlled Substances Product Introduction
  • 14.2.3 Teva Pharmaceuticals Controlled Substances Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.2.4 SWOT Analysis
• 14.3 Takeda Pharmaceutical
  • 14.3.1 Company Information
  • 14.3.2 Controlled Substances Product Introduction
  • 14.3.3 Takeda Pharmaceutical Controlled Substances Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.3.4 SWOT Analysis
• 14.4 Sun Pharmaceutical
  • 14.4.1 Company Information
  • 14.4.2 Controlled Substances Product Introduction
  • 14.4.3 Sun Pharmaceutical Controlled Substances Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.4.4 SWOT Analysis
• 14.5 Siegfried AG
  • 14.5.1 Company Information
  • 14.5.2 Controlled Substances Product Introduction
  • 14.5.3 Siegfried AG Controlled Substances Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.5.4 SWOT Analysis
• 14.6 Purdue Pharma
  • 14.6.1 Company Information
  • 14.6.2 Controlled Substances Product Introduction
  • 14.6.3 Purdue Pharma Controlled Substances Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.6.4 SWOT Analysis
• 14.7 Pfizer
  • 14.7.1 Company Information
  • 14.7.2 Controlled Substances Product Introduction
  • 14.7.3 Pfizer Controlled Substances Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.7.4 SWOT Analysis
• 14.8 Mylan
  • 14.8.1 Company Information
  • 14.8.2 Controlled Substances Product Introduction
  • 14.8.3 Mylan Controlled Substances Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.8.4 SWOT Analysis
• 14.9 Medical Marijuana, Inc
  • 14.9.1 Company Information
  • 14.9.2 Controlled Substances Product Introduction
  • 14.9.3 Medical Marijuana, Inc Controlled Substances Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.9.4 SWOT Analysis
• 14.10 Johnson & Johnson
  • 14.10.1 Company Information
  • 14.10.2 Controlled Substances Product Introduction
  • 14.10.3 Johnson & Johnson Controlled Substances Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.10.4 SWOT Analysis
• 14.11 GlaxoSmithKline
• 14.12 Daiichi Sankyo
• 14.13 Consort Medical
• 14.14 Akorn Inc

15 Conclusion

16 Methodology

Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Controlled Substances market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Controlled Substances market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
Opioids
Stimulants
Depressants
Marijuana
Others

Segmented by End User/Segment
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Tilray
Teva Pharmaceuticals
Takeda Pharmaceutical
Sun Pharmaceutical
Siegfried AG
Purdue Pharma
Pfizer
Mylan
Medical Marijuana, Inc
Johnson & Johnson
GlaxoSmithKline
Daiichi Sankyo
Consort Medical
Akorn Inc